PriceTargets.com logo

Ardent Health Partners - ARDT Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $21.82
  • Forecasted Upside: 32.63%
  • Number of Analysts: 12
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 8 Buy Ratings
  • 2 Strong Buy Ratings
$16.45 As of 11/20/2024 01:00 AM ET
▼ -0.19 (-1.14%)

This chart shows the closing price for ARDT by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Ardent Health Partners Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ARDT and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ARDT

Analyst Price Target is $21.82
▲ +32.63% Upside Potential
This price target is based on 12 analysts offering 12 month price targets for Ardent Health Partners in the last 3 months. The average price target is $21.82, with a high forecast of $27.00 and a low forecast of $18.00. The average price target represents a 32.63% upside from the last price of $16.45.

This chart shows the closing price for ARDT for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Buy

The current consensus among 12 investment analysts is to buy stock in Ardent Health Partners.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/30/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/28/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/26/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/24/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/24/2024
  • 1 strong buy ratings
  • 9 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
8/22/2024
  • 2 strong buy ratings
  • 9 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
10/21/2024
  • 2 strong buy ratings
  • 8 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
11/20/2024

Latest Recommendations

  • 2 strong buy ratings
  • 8 buy ratings
  • 2 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
11/14/2024Royal Bank of CanadaReiterated RatingOutperform ➝ Outperform$23.00 ➝ $23.00
11/12/2024Leerink PartnersBoost TargetOutperform ➝ Outperform$23.00 ➝ $25.00
11/6/2024Bank of AmericaDowngradeBuy ➝ Neutral$22.00 ➝ $19.00
10/11/2024KeyCorpInitiated CoverageOverweight$24.00
10/10/2024KeyCorpUpgradeStrong-Buy
9/19/2024StephensReiterated RatingOverweight ➝ Overweight$24.00 ➝ $24.00
8/12/2024Leerink PartnrsUpgradeStrong-Buy
8/12/2024Bank of AmericaInitiated CoverageBuy$22.00
8/12/2024Loop CapitalInitiated CoverageBuy ➝ Buy$18.00 ➝ $18.00
8/12/2024StephensInitiated CoverageOverweight ➝ Overweight$24.00 ➝ $24.00
8/12/2024CitigroupInitiated CoverageBuy$21.00
8/12/2024Royal Bank of CanadaInitiated CoverageOutperform$23.00
8/12/2024Morgan StanleyInitiated CoverageOverweight$27.00
8/12/2024JPMorgan Chase & Co.Initiated CoverageNeutral$18.00
8/12/2024MizuhoInitiated CoverageOutperform$20.00
8/12/2024Leerink PartnersInitiated CoverageOutperform$23.00
8/12/2024Truist FinancialInitiated CoverageBuy ➝ Buy$21.00 ➝ $21.00
(Data available from 11/21/2019 forward)

News Sentiment Rating

0.88 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/24/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/24/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/23/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/23/2024
  • 9 very positive mentions
  • 11 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/22/2024
  • 2 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/21/2024
  • 6 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/21/2024
  • 15 very positive mentions
  • 9 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
11/20/2024

Current Sentiment

  • 15 very positive mentions
  • 9 positive mentions
  • 2 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

Ardent Health Partners logo
Ardent Health Partners, Inc. owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health Partners, Inc. is a subsidiary of EGI-AM Investments, L.L.C.
Read More

Today's Range

Now: $16.45
Low: $16.35
High: $16.76

50 Day Range

MA: $18.13
Low: $16.25
High: $20.19

52 Week Range

Now: $16.45
Low: $14.57
High: $20.72

Volume

180,749 shs

Average Volume

367,102 shs

Market Capitalization

$2.35 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Ardent Health Partners?

The following sell-side analysts have issued reports on Ardent Health Partners in the last year: Bank of America Co., Citigroup Inc., JPMorgan Chase & Co., KeyCorp, Leerink Partners, Leerink Partnrs, Loop Capital, Mizuho, Morgan Stanley, Royal Bank of Canada, Stephens, and Truist Financial Co..
View the latest analyst ratings for ARDT.

What is the current price target for Ardent Health Partners?

0 Wall Street analysts have set twelve-month price targets for Ardent Health Partners in the last year. Their average twelve-month price target is $21.82, suggesting a possible upside of 32.7%. Morgan Stanley has the highest price target set, predicting ARDT will reach $27.00 in the next twelve months. JPMorgan Chase & Co. has the lowest price target set, forecasting a price of $18.00 for Ardent Health Partners in the next year.
View the latest price targets for ARDT.

What is the current consensus analyst rating for Ardent Health Partners?

Ardent Health Partners currently has 2 hold ratings, 8 buy ratings and 2 strong buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe ARDT will outperform the market and that investors should add to their positions of Ardent Health Partners.
View the latest ratings for ARDT.

What other companies compete with Ardent Health Partners?

Other companies that are similar to Ardent Health Partners include Hims & Hers Health, Guardant Health, Sotera Health, Option Care Health and BrightSpring Health Services. Learn More about companies similar to Ardent Health Partners.

How do I contact Ardent Health Partners' investor relations team?

Ardent Health Partners' physical mailing address is ONE BURTON HILLS BLVD, SUITE 250, NASHVILLE, TN, 37215. The company's listed phone number is (615) 296-3000 and its investor relations email address is [email protected]. The official website for Ardent Health Partners is ardenthealth.com. Learn More about contacing Ardent Health Partners investor relations.